Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Apogee Therapeutics, Inc. - Common Stock
(NQ:
APGE
)
47.50
-0.02 (-0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
268,668
Open
47.60
Bid (Size)
44.44 (1)
Ask (Size)
48.50 (1)
Prev. Close
47.52
Today's Range
45.70 - 47.85
52wk Range
14.19 - 72.29
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors
July 18, 2024
From
NewAmsterdam Pharma N.V.
Via
GlobeNewswire
XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
July 14, 2024
10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit...
Via
Benzinga
Performance
YTD
+66.61%
+66.61%
1 Month
+24.84%
+24.84%
3 Month
-2.34%
-2.34%
6 Month
+38.00%
+38.00%
1 Year
+132.84%
+132.84%
More News
Read More
Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
July 11, 2024
Via
Benzinga
Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
May 28, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
Apogee Therapeutics to Participate in Upcoming June Investor Conferences
May 23, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
Apogee Announces Dosing of First Patient in Phase 2 Atopic Dermatitis Trial of APG777, a Novel Subcutaneous Half-life Extended Anti-IL-13 Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases
May 15, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
APGE Stock Earnings: Apogee Therapeutics Misses EPS for Q1 2024
May 13, 2024
Via
InvestorPlace
Apogee Therapeutics Highlights Pipeline Progress and Reports First Quarter 2024 Financial Results
May 13, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
Earnings Superstars: 3 Stocks Primed to Outperform This Quarter
May 08, 2024
Via
InvestorPlace
Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
May 06, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Trial of APG808, its Novel Half-life Extended IL-4Rα Antibody for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) and Other Inflammatory Diseases
March 25, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
March 14, 2024
Via
Benzinga
Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million
March 12, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
Apogee Therapeutics, Inc. Announces Pricing of Upsized $420 Million Underwritten Public Offering
March 07, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
APGE Stock Earnings: Apogee Therapeutics Beats EPS for Q4 2023
March 05, 2024
Via
InvestorPlace
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering
March 05, 2024
From
Apogee Therapeutics, LLC
Via
GlobeNewswire
Crude Oil Down 1%; Dave Shares Jump After Q4 Results
March 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 05, 2024
Via
Benzinga
Nasdaq Down 250 Points; ISM Services PMI Falls In February
March 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Atopic Dermatitis-Focused Apogee Therapeutics Stock Trading Higher On Tuesday?
March 05, 2024
Via
Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
March 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Dips Over 100 Points; Target Posts Upbeat Earnings
March 05, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 05, 2024
Via
Benzinga
IPO Stock Apogee Shifts Higher On Solid Phase 1 Outcome
March 05, 2024
Via
Investor's Business Daily
Topics
Initial Public Offering
Exposures
Securities Market
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.